Anti-Mullerian Hormone (AMH) Versus Antral Follicle Count (AFC) Guided rFSH Dosing Study
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The overall objectives of this trial are to:
- To explore the efficacy and safety of using either antral follicle count (AFC) or
anti-Mullerian hormone (AMH) to guide the starting dose of GONAL-f® in ovarian
stimulation for Assisted Reproductive Technology (ART).
- To assess the differences in both ovarian response and clinical pregnancy rate between
subjects with different AFC and AMH levels undergoing ART.